Showing posts with label +. Show all posts
Showing posts with label +. Show all posts

Thursday, 11 December 2025

THRIVING IN EVERY MARKET -Value Investing Made Easy

THRIVING IN EVERY MARKET

Value Investing Made Easy (Janet Lowe):
  1. THRIVING IN EVERY MARKET
  2. MR. MARKET
  3. SUITABLE SECURITIES AT SUITABLE PRICES
  4. PAYING RESPECT TO THE MARKET
  5. TIMING VERSUS PRICING
  6. BELIEVING A BULL MARKET
  7. THE PAUSE AT THE TOP OF THE ROLLER COASTER
  8. MAKING FRIENDS WITH A BEAR
  9. BARGAINS AT THE BOTTOM
  10. SIGNS AT THE BOTTOM
  11. BUYING TIME
  12. IF YOU ABSOLUTELY MUST PLAY THE HORSES



THRIVING IN EVERY MARKET

This passage explores the irrational nature of the market and how value investors navigate it.

  • Market Irrationality: Unlike normal consumer behavior, investors often buy stocks at high prices and avoid them at low prices. Markets are prone to overreact, swinging wildly above and below intrinsic value—a behavior likened to a hunting dog frenetically searching for a scent.

  • The 1987 Crash Example: The rapid 44% rise and subsequent 23% single-day crash in 1987 demonstrated that market prices can dramatically diverge from the underlying value of businesses.

  • Mr. Market's "Scatterbrained" Behavior: The case of Chrysler in 1995 shows how a stock can remain undervalued until an event (like a takeover bid) suddenly corrects the price, revealing the market's emotional and erratic pricing mechanism.

  • The Value Investor's Approach: Value investors acknowledge and use market cycles (the "wavelike advances and retreats") but do not try to predict their timing or extremes. Instead, they focus on buying undervalued stocks, knowing that market fluctuations will eventually correct the price toward intrinsic value, which is essential for their success.




MR. MARKET

This passage introduces the allegory of "Mr. Market," created by Benjamin Graham to illustrate the stock market's irrational and emotional behavior.

Mr. Market is depicted as a manic-depressive, compulsive business partner who offers to buy or sell you shares every day. His prices are driven by his volatile moods—euphoric optimism leads to unrealistically high offers, while pessimism leads to absurdly low ones. However, his mood swings are irrelevant to the underlying value of the business.

The key lesson is that Mr. Market exists to serve you, not guide you. A wise investor should ignore his emotional extremes and only act when his price is advantageous—buying when he is irrationally pessimistic and selling when he is overly optimistic. His offers are opportunities to be used, not signals to follow.




SUITABLE SECURITIES AT SUITABLE PRICES

This passage outlines the core value investing principle of focusing on price rather than prediction.

The investor's main goal is to acquire and hold suitable securities at suitable (low) prices. Market movements are practically useful only because they create these opportunities: low prices to buy and high prices to avoid buying or to sell.

However, while these market cycles are obvious in hindsight, they are impossible to predict in advance. The investor's success depends on both the market's future behavior and the prices it offers, yet neither can be controlled or forecasted. Therefore, the strategy relies on disciplined action when prices are favorable, not on trying to time the market's unpredictable turns.




PAYING RESPECT TO THE MARKET

Value investors and market timers share two key beliefs: the market frequently misprices assets away from their true value, and it eventually corrects to align with that value.

While value investors don't try to predict the exact timing of market highs and lows, they agree with timers that market movements are fundamentally linked to intrinsic value. They operate on the conviction that, due to changing conditions or investor recognition, a stock's price will ultimately rise or fall to reflect its actual worth, just as the moon influences the tides.




TIMING VERSUS PRICING

Value investors can exploit market swings through two methods: timing (predicting movements in advance) or pricing (acting based on established value).

Research shows that timing is ineffective and unreliable, as most attempts to predict the market fail to outperform a simple buy-and-hold strategy.

Therefore, Graham advocated the pricing approach. This means:

  • Buying only after a decline has occurred and securities are demonstrably undervalued.

  • Selling only after a bull market has pushed prices above intrinsic value.

By following this disciplined cycle—selling overvalued assets to hold cash, then using that cash to buy bargains during downturns—investors can exploit market swings after they happen, without needing to predict them.




BELIEVING A BULL MARKET

During a bull market, value investing becomes unpopular as speculative stocks surge, making value stocks seem boring in comparison. However, value stocks regain their appeal as stable, reliable holdings during a market correction.

Bull markets are typically characterized by:

  • High Prices: Price levels and P/E ratios are historically elevated.

  • Low Dividend Yields: Yields are low relative to bonds or the stock's own history.

  • Speculative Excess: There is heavy margin buying (borrowing to invest) and a flood of new stock offerings, particularly low-quality IPOs, which seasoned investors often view as overpriced during these periods.




THE PAUSE AT THE TOP OF THE ROLLER COASTER

When the market is at a high point, a value investor's only effective strategy is patience. They have two options, both requiring steady nerves:
  1. Sell everything, take profits, and wait for a market decline to find new bargains.

  2. Hold stocks with long-term potential, selling only the clearly overvalued ones, and again wait for a decline.

This patience pays off during a correction, as well-chosen value stocks tend to hold their price better. The example of Walter Schloss in 1987 shows that while value portfolios may lag in a bull market's peak, they often protect capital and outperform during downturns, preserving long-term returns.

In contrast, speculative "hot stocks" that crash put investors in a difficult position: selling locks in permanent losses, while holding on involves a long, erosionary recovery.




MAKING FRIENDS WITH A BEAR

This passage recounts Benjamin Graham's experience with the 1929 crash and its aftermath.

Even though he recognized the market was dangerously high and had carefully chosen and hedged his investments, Graham was still badly damaged by the crash due to incomplete hedges and excessive use of borrowed money (margin).

Despite these losses, he persevered, rebuilt his portfolio, and soon played a key role in triggering a market recovery by publicly declaring it was time to start buying again. His story illustrates both the severe risks of a crash and the resilience of a disciplined value investor.




BARGAINS AT THE BOTTOM

This article highlights how Benjamin Graham repeatedly identified and publicized extreme undervaluation in the stock market to spur recovery.
  • In 1932, during the Great Depression, Graham survived through various financial jobs and began buying defunct companies.

  • In 1942, he published a series in Forbes noting that many companies were trading for less than their cash holdings. His argument that businesses were "worth more dead than alive" gave discouraged investors confidence and helped start a sustained market recovery.

  • In 1974, during another market downturn, Graham gave a speech declaring a "Renaissance of Value," noting that stocks were again deeply discounted. He urged investment managers to buy these bargains. His call contributed to a market revival, with the Dow Jones Industrial Average rising from 600 to over 900 by 1976.

The core theme is Graham's repeated use of value investing principles—buying stocks far below their intrinsic value—to signal market bottoms and inspire investor action.





SIGNS AT THE BOTTOM

This passage explains that identifying a market bottom is theoretically simpler than spotting a top, based on clear quantitative evidence.

The key signs are found in corporate financial data (like balance sheets and P/E ratios) and in broad market metrics. As a primary example, it states that the dividend yield for the Dow Jones Industrial Average historically cycles between approximately 6% at a market bottom (signaling undervaluation) and 3% at a market top (signaling overvaluation). While it can sometimes move beyond these points, this yield range is presented as a reliable historical indicator.




BUYING TIME

This passage explains that a falling market is the ideal time for value investors to buy, but it requires overcoming fear and exercising patience.

  • Opportunity in Downturns: When markets fall sharply, value investors see a "harvest time" with many undervalued companies available. Figures like Seth Klarman and Warren Buffett view these periods as advantageous.

  • The Psychological Hurdle: This best buying time coincides with widespread investor fear and negativity, making it psychologically difficult to act.

  • The Strategy: The key is to buy affordable undervalued stocks during these bear market depths, as bargains are not found in strong markets.

  • The Need for Patience: Undervalued stocks often remain dormant for long periods. Therefore, successful investing requires identifying a bargain, taking a position, and then waiting—often a protracted and trying experience—for the market to recognize the value.




IF YOU ABSOLUTELY MUST PLAY THE HORSES

This passage outlines a strict, disciplined strategy for combining market timing with value investing, as acknowledged (but not recommended) by Benjamin Graham.

The method, attributed to Roger Babson, is structured and demands significant patience, as it may cause an investor to miss parts of a bull market. The strategy works as follows:

  1. Select: Choose a diversified portfolio of stocks, such as those in the DJIA, focusing on undervalued ones.

  2. Value: Determine a "normal value" for each stock using a multiplier applied to its 7-10 year average earnings.

  3. Buy: Purchase shares only when they trade at a substantial discount (e.g., two-thirds) to that normal value, potentially starting to buy as the price declines to 80% of value.

  4. Sell: Sell the stocks when their price rises substantially above normal value (e.g., 20-50% higher).

The core mechanism is to buy during market declines and sell during rallies, based strictly on predetermined price-to-value calculations rather than emotion.

Zetrix AI - technical analysis











Based on the provided chart and data, here is a technical analysis of ZETRIX AI BERHAD on Bursa Malaysia:


1. Price Action & Current Status

  • Last Close: 0.835

  • Change: -0.005 (-0.60%)

  • Day Range: 0.825 – 0.845

  • The stock is trading below its 200-day MA (0.889), indicating a long-term downtrend.

  • It is, however, above its 10-day MA (0.821), suggesting short-term support and possible consolidation.


2. Moving Averages (Trend Analysis)

  • MA 10 (0.821): Price above this suggests recent buying interest.

  • MA 200 (0.889): Price significantly below → bearish long-term trend.

  • The gap between these MAs confirms ongoing downward pressure over the medium to long term.


3. Bollinger Bands (Volatility & Price Levels)

  • BB (20,2):

    • Upper: 0.854

    • Middle: 0.826

    • Lower: 0.798

  • Price is near the middle band, indicating neutral momentum in the short term.

  • Lower band (0.798) acts as near-term support; upper band (0.854) as resistance.


4. MACD (Momentum)

  • MACD (12,26,9):

    • MACD Line: 0.001

    • Signal Line: -0.005

    • Histogram: -0.006 (slightly negative)

  • MACD is near zero, indicating weak momentum and potential consolidation.

  • Slight negative histogram suggests mild selling pressure.


5. RSI (Relative Strength Index)

  • RSI 14: 43.83

  • This is in neutral territory (neither overbought nor oversold).

  • Suggests no extreme buying or selling pressure at the moment.


6. Volume

  • Volume: 40.491M

  • Compared to previous levels (59.338M shown), volume is lower, suggesting lack of strong conviction in recent price moves.


7. Chart Pattern & Key Levels

  • Long-term view (Mar 2024 – Nov 2025 chart):

    • Stock peaked around 1.10–1.15 in early-mid 2024.

    • Since then, it has been in a downtrend, making lower highs and lower lows.

    • Recent lows around 0.680–0.700 (late 2024) provided a base, but recovery has been weak.

  • Current trading range: 0.800–0.850.

  • Major resistance: 0.889 (200 MA) and 0.950 (previous support turned resistance).

  • Major support: 0.798 (BB lower) and 0.680 (2024 low).


8. Overall Outlook

  • Short-term: Neutral to slightly bearish. Price is consolidating between 0.798 and 0.854.

  • Medium-term: Bearish, as long as price stays below 200 MA (0.889).

  • Long-term: Downtrend intact unless price breaks above 0.950 with volume.


9. Investor/Trader Takeaways

  • For traders: Range-bound strategies between 0.80–0.85 could work. A break below 0.798 may signal a retest of 0.750–0.680.

  • For investors: Not yet a clear reversal signal. Wait for a break above 0.889 (200 MA) with strong volume for trend change confirmation.

  • Watch: MACD turning positive, RSI moving above 50, and volume increase on up-days for bullish reversal signs.


Summary

ZETRIX AI is in a long-term downtrend but currently in a short-term consolidation phase. Key levels to watch are 0.798 (support) and 0.889 (resistance). The lack of strong volume and momentum indicators suggests caution. A decisive break above 0.889 could shift sentiment, while a break below 0.798 could resume the downtrend.

This response is AI-generated

TIMING VERSUS PRICING

 TIMING VERSUS PRICING

https://myinvestingnotes.blogspot.com/2009/01/timing-versus-pricing.html

Analysis & Discussion

The passage presents a clear, logical framework for navigating market cycles, grounded in the philosophy of Benjamin Graham, the father of value investing. It contrasts two primary methods and argues decisively for one over the other.

1. The Futility of Timing (Anticipation)

  • The Claim: Actively predicting the peaks and troughs of the market ("timing") is presented as unreliable and ultimately a losing strategy for most. The 1995 study cited is powerful evidence—it shows that even professional forecasters (newsletters) fail to outperform a simple, passive benchmark consistently. The "less than 50% chance" of a third successful year highlights the randomness of short-term success in timing.

  • The Reality Check: This view is overwhelmingly supported by modern financial research. The majority of active fund managers underperform their benchmarks over the long term, and significant market moves often occur in very short, unpredictable bursts. Missing just a few of the best days can drastically reduce long-term returns. Timing requires being right twice: knowing when to exit and when to re-enter. The psychological and practical difficulty of this is immense.

2. The Power of Pricing (Reaction)

  • The Mechanism: Graham's "pricing" approach flips the script. Instead of anticipating swings, it reacts to their consequences. It is a rules-based, valuation-driven discipline:

    • Buy: When market declines have created clear undervaluation relative to a security's intrinsic value.

    • Sell: When market euphoria has pushed prices to a significant premium over intrinsic value.

  • The Critical Link to Value Investing: This is not mere "buying the dip." The key is the objective benchmark of intrinsic value. An investor must have a method for estimating what a company is truly worth, independent of its market price. This requires fundamental analysis (of assets, earnings, dividends, stability, etc.).

  • The Behavioral and Strategic Advantage: This approach enforces discipline and counteracts emotional decisions ("Buy when others are fearful..."). Most importantly, it ensures you are always acting on a known condition (current price vs. intrinsic value) rather than an unknown prediction (where the market will go next). Holding cash after selling overvalued assets is framed not as a loss of opportunity, but as strategic reserve capital—"dry powder" for future opportunities.

3. Key Implications and Comments

  • It's a Strategy for Patient Capital: This approach can involve long periods of inactivity or underperformance. Holding cash in a raging bull market or buying in a crashing bear market is psychologically taxing and requires deep conviction.

  • The Challenge of Intrinsic Value: The entire "pricing" strategy hinges on accurately calculating intrinsic value, which is an estimate, not a precise number. Different valuation models can yield different results. The skill of the investor lies in making a conservative, reasoned estimate.

  • Works Best with Individual Securities: While the principle applies to the overall market (e.g., using broad metrics like the CAPE ratio), it is most effectively applied stock-by-stock. A market may be fairly valued, but specific companies can be deeply undervalued due to non-systemic reasons.

  • A Form of "Opportunistic Asset Allocation": The strategy effectively dynamically adjusts your portfolio's allocation between "risky assets" (undervalued securities) and "safe assets" (cash) based on market valuation, not on a fixed calendar schedule. This is a sophisticated form of long-term asset allocation.

  • Not "Set and Forget": Unlike pure buy-and-hold (which the passage uses to beat timing), the pricing approach is an active value strategy. It requires ongoing analysis, monitoring, and the courage to act decisively when prices diverge extremely from value.

Summary

The passage argues that attempting to time the market (anticipate swings) is a proven loser's game for most investors. Instead, the wise approach is to exploit market cycles through pricing. This means:

  1. Ignore predictions about future market direction.

  2. Focus relentlessly on the relationship between a security's current market price and its calculated intrinsic value.

  3. Buy only when price is significantly below intrinsic value (after a decline has occurred), and sell when price rises to a substantial premium.

  4. Preserve cash from sales to deploy during future periods of undervaluation.

In essence: Don't try to predict the cycle; let the cycle's extreme price movements create your opportunities. Your guide is not a forecast, but a disciplined valuation model. This transforms market volatility from a source of risk into a source of opportunity, provided one has the patience, discipline, and analytical skill to execute it.

S&P500, EPS growth, Change in P/E. Relationship between Earnings and Valuation

 











This chart is titled "Earnings vs Valuation" and shows two overlaid time series from January 1996 through what appears to be late 2024 or early 2025, based on the x-axis.

Here's a breakdown of its elements and what it's communicating:


1. What’s being plotted

  • Right y-axis: Trailing EPS (Earnings Per Share) growth rate (year-over-year percentage change).

  • Left y-axis: S&P 500 index level (logarithmic scale).

  • Vertical shaded bars indicate recessions (based on NBER dating).

  • Arrow lines mark peaks in EPS growth just before significant slowdowns or declines.


2. Key observations from the chart

A) Earnings Growth 

  • Highly cyclical, closely tied to economic recessions (gray bars).

  • Sharp drops in EPS growth occurred during:

    • 2001 recession (dot-com bust)

    • 2008–2009 financial crisis (deepest drop, below –30%)

    • 2020 COVID-19 recession (brief but sharp fall)

    • 2022–? slowdown (post-pandemic, with inflation and tightening)

  • Peak growth periods often precede downturns (marked by arrows).

B) Stock Market Valuation (Gray Line – S&P 500)

  • Despite earnings volatility, the S&P 500 has trended upward over the long term (log scale shows consistent compounding).

  • Notable corrections align with earnings recessions:

    • 2000–2002

    • 2008–2009

    • 2020 (brief)

    • 2022 (valuation reset as rates rose)

  • Market doesn’t always fall when earnings slow if future growth is anticipated or rates are low (e.g., post-2010).

C) Recent Data (2022–2024)

  • EPS growth peaked around late 2021 / early 2022 at very high levels (~50% year-over-year, likely due to post-COVID recovery and stimulus).

  • Growth then slowed sharply through 2022–2023 but remained positive in late 2023 / early 2024.

  • S&P 500 continued rising even as EPS growth normalized — suggesting valuation expansion (P/E multiple increase) possibly due to AI optimism, easing inflation expectations, or Fed pivot hopes.


3. Interpretation & Discussion Points

  1. Earnings cyclicality vs. market trend
    Earnings are much more volatile than stock prices in the long run. The market smooths out short-term earnings shocks by looking ahead.

  2. Valuation expansion in late cycle
    In recent years (2023–2024), S&P 500 kept rising despite slowing EPS growth. This implies higher P/E ratios, which can be justified by lower interest rate expectations, technological disruption (AI), or liquidity. It also raises questions about market overvaluation if earnings don’t re-accelerate.

  3. Peak growth as a signal
    Chart highlights that when EPS growth peaks at very high levels (e.g., >30%), it often precedes a slowdown or recession. The 2021–2022 peak was exceptionally high due to easy comps and fiscal stimulus — the subsequent deceleration was expected.

  4. Forward-looking market
    The market often bottoms before earnings trough (e.g., late 2008/early 2009 rally before earnings recovered; 2020 March low before V-shaped EPS rebound).

  5. Current context (end of chart)
    EPS growth appears to be modestly positive, S&P 500 near highs — suggests market betting on a soft landing and future earnings recovery rather than an imminent recession.


4. Investment Implications

  • Watching EPS growth momentum can help identify cycle turns.

  • High valuation + decelerating earnings = potential vulnerability if macro deteriorates.

  • Long-term investors benefit from looking through earnings cycles, as market trend has been upward despite periodic 30%+ EPS drops.

This chart essentially tells a story of short-term earnings volatility within a long-term bullish equity trend, with recent years showing a notable disconnect between earnings growth and market performance — likely driven by liquidity, interest rates, and long-term growth expectations.

This response is AI-generated

Wednesday, 10 December 2025

Johnson & Johnson: has a secure growing income stream and ability to deploy massive capital for high-return growth

Here is a comprehensive summary of Johnson & Johnson's financial statements and an overall assessment.

1. Income Statement Summary: The Earnings Story

  • Core Business is Healthy & Growing: After the 2022 dip due to the Kenvue spin-off, revenue has returned to steady growth (4.3% in 2024). Underlying growth in Pharma and MedTech is solid.

  • Exceptional Profitability: The company boasts a very high Gross Profit Margin (~69%), showcasing its pricing power and efficient production in high-margin healthcare sectors.

  • Earnings Distorted by One-Time Events: Reported Net Income is heavily impacted by massive "Unusual Expenses" ($6.2B in 2024) and the 2023 spin-off gain. Look at EBITDA (~$28B, margin ~32%) for operational performance.

  • Heavy Investment in the Future: R&D spending is high and increasing ($17.3B in 2024), reflecting commitment to the pharmaceutical pipeline.

  • Recent Quarter (Q3 2025) Shows Strength: Excluding a one-time gain in Q1 2025, pretax income trended up to $7.5B in Q3 2025, indicating improving core operations.

Key Takeaway: The underlying business is robust and profitable. Ignore the noise from spin-off/restructuring costs; focus on sales growth and EBITDA margins.

2. Balance Sheet Summary: The Financial Fortress

  • Extremely Strong & Conservative: The balance sheet is a key strength. Leverage is very low (Debt-to-Equity ~0.58), providing immense resilience and flexibility.

  • War Chest of Liquidity: Cash holdings are substantial (~$18.6B) even after a major acquisition, providing dry powder for more strategic moves.

  • Asset-Light, IP-Heavy Model: Assets are dominated by Intangibles ($96.8B, ~50% of assets) like patents and brands, not factories. This is typical for a pharma/medtech innovator.

  • Shareholder-Friendly: An enormous Treasury Stock balance (~$75.9B) evidences decades of aggressive share buybacks, a core pillar of capital return.

  • Post-Spin-Off Reshuffling: The surge and subsequent reduction in cash and short-term debt in 2025 show active liability management and strategic deployment of capital from the Kenvue separation.

Key Takeaway: J&J has a AAA-quality balance sheet. It is not just strong; it is a strategic weapon enabling bold M&A without undue risk.

3. Cash Flow Statement Summary: The Engine & Its Use

  • Powerful Cash Generation: Operating Cash Flow (OCF) is the engine, generating a massive ~$24B annually with superb margins (25-28% of Sales). Earnings are high quality and convert to cash.

  • Disciplined Investment: Capital Expenditures are low (~4-5% of Sales), but Strategic Acquisitions are significant ($15.1B in 2024, $14.5B in Q2 2025). This is how J&J buys growth.

  • Predictable, Generous Shareholder Returns: Dividends are sacrosanct, steady, and growing (~$11.8B annually). Share buybacks are consistently executed.

  • Prudent Financing: Debt is used strategically to fund large acquisitions (e.g., $15.1B issued in Q1 2025), which is then rapidly paid down from the copious OCF.

  • Strong Free Cash Flow: Annual Free Cash Flow is consistently robust ($17-20B), funding all priorities comfortably.

Key Takeaway: J&J follows a classic blue-chip cash cycle: Generate massive OCF → Fund growth via M&A → Return all excess cash to shareholders. The model is executed flawlessly.


Overall Financial Summary & Investment Thesis

Johnson & Johnson is a financially elite company transitioning strategically from a diversified conglomerate to a focused healthcare innovator.

  • Financial Health: Excellent (A+). The combination of high profitability, a fortress balance sheet, and immense, predictable cash flows places J&J in the top tier of corporate financial health globally. There is minimal solvency or liquidity risk.

  • Strategy & Capital Allocation: Clear and Active.

    1. Invest for Growth: Major, ongoing R&D spend combined with bold, bolt-on acquisitions (evident in 2024-2025 cash flows) to strengthen Pharma and MedTech.

    2. Return Capital Reliably: A dependable, growing dividend and consistent share buybacks.

    3. Maintain Financial Strength: Using debt strategically but always quickly returning to conservative leverage ratios.

  • Investment Profile:

    • Defensive Core: Provides stability through reliable dividends and recession-resistant cash flows.

    • Growth Optionality: Offers potential for acceleration through its R&D pipeline and strategic M&A, funded by its unparalleled balance sheet.

    • Low Risk: The financial structure inherently reduces downside risk.

Bottom Line: Johnson & Johnson is not just weathering its corporate transformation; it is leveraging its unparalleled financial strength to aggressively shape its future. An investor is buying a secure, growing income stream coupled with a call option on management's ability to wisely deploy a massive war chest for high-return growth. The primary watch item is no longer the spin-off—it is the execution and integration of its new acquisitions.